Ligand Pharmaceuticals Inc (LGND)
Cash & Equivalents
$1.01B
Quarterly · Period ending: · USD
LGND Cash & Equivalents
Latest reported$1.01Bperiod ending
Latest reported$1.01Bperiod ending
LGND Quarterly Cash & Equivalents ($2.10M → $1.01B)
Quarterly Cash & Equivalents
High-resolution chart · PNG
LGND cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 28,600,000 | |
| 20,972,000 | |
| 9,224,000 | |
| 11,969,000 | |
| 23,157,000 | |
| 23,877,000 | |
| 29,900,000 | |
| 26,700,000 | |
| 8,400,000 | |
| 11,000,000 | |
| 32,800,000 | |
| 24,900,000 | |
| 25,600,000 | |
| 26,100,000 | |
| 62,300,000 | |
| 13,400,000 | |
| 17,700,000 | |
| 22,800,000 | |
| 34,800,000 | |
| 7,000,000 | |
| 11,200,000 | |
| 16,500,000 | |
| 16,000,000 | |
| 12,200,000 | |
| 13,300,000 | |
| 7,600,000 | |
| 12,100,000 | |
| 700,000 | |
| 2,100,000 |